Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

BioArctic Interim Report for the period October - December 2025

Contributed by: PR Newswire

Tags

BioArctic-Interim-Rep

More Like This

Interim Report for the period July - September 2025: BioArctic

BioArctic: Interim Report for the period April - June 2025

Sales of Leqembi® totaled 20.7 billion yen in the fourth quarter 2025

Eisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026)

Sales of Leqembi® totaled 18 billion yen in the third quarter 2025

Eisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025). Sales now expected to reach JPY 42.5 billion

Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March 2025)

LEQEMBI® Q3 2023 sales published - 0.4 billion yen recorded in the period

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us